First Relief Neurostimulation Device Cleared for Diabetic Neuropathic Pain

DyAnsys’ First Relief PENS (percutaneous electrical neurostimulation) device has been granted FDA approval for multiple treatments for up to 56 days for the relief of chronic diabetic peripheral neuropathy-related pain. This wearable device, which attaches to the ear, emits continuous pulses of low-level electrical current over a period of several days...